Brain Food for Alzheimer-Free Ageing: Focus on Herbal Medicines

  • Helmut M. HügelEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 863)


Healthy brain aging and the problems of dementia and Alzheimer’s disease (AD) are a global concern. Beyond 60 years of age, most, if not everyone, will experience a decline in cognitive skills, memory capacity and changes in brain structure. Longevity eventually leads to an accumulation of amyloid plaques and/or tau tangles, including some vascular dementia damage. Therefore, lifestyle choices are paramount to leading either a brain-derived or a brain-deprived life. The focus of this review is to critically examine the evidence, impact, influence and mechanisms of natural products as chemopreventive agents which induce therapeutic outcomes that modulate the aggregation process of beta-amyloid (Aβ), providing measureable cognitive benefits in the aging process. Plants can be considered as chemical factories that manufacture huge numbers of diverse bioactive substances, many of which have the potential to provide substantial neuroprotective benefits. Medicinal herbs and health food supplements have been widely used in Asia since over 2,000 years. The phytochemicals utilized in traditional Chinese medicine have demonstrated safety profiles for human consumption. Many herbs with anti-amyloidogenic activity, including those containing polyphenolic constituents such as green tea, turmeric, Salvia miltiorrhiza, and Panax ginseng, are presented. Also covered in this review are extracts from kitchen spices including cinnamon, ginger, rosemary, sage, salvia herbs, Chinese celery and many others some of which are commonly used in herbal combinations and represent highly promising therapeutic natural compounds against AD. A number of clinical trials conducted on herbs to counter dementia and AD are discussed.


Alzheimer’s disease Dementia Amyloid-beta Traditional Chinese medicine (TCM) Herbal polyphenols 


  1. Airoldi C, Sironi E, Dias C, Marcelo F, Martins A, Rauter AP, Nicotra F, Jimenez-Barbero J (2013) Natural compounds against Alzheimer’s disease: molecular recognition of Abeta1-42 peptide by Salvia sclareoides extract and its major component, rosmarinic acid, as investigated by NMR. Chem Asian J 8(3):596–602. doi: 10.1002/asia.201201063 PubMedGoogle Scholar
  2. Bae EA, Hyun YJ, Choo MK, Oh JK, Ryu JH, Kim DH (2004) Protective effect of fermented red ginseng on a transient focal ischemic rats. Arch Pharm Res 27(11):1136–1140PubMedGoogle Scholar
  3. Bao XQ, Kong XC, Qian C, Zhang D (2012) FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson’s disease models. Neuroscience 202:396–404. doi: 10.1016/j.neuroscience.2011.11.036 PubMedGoogle Scholar
  4. Bao XQ, Li N, Wang T, Kong XC, Tai WJ, Sun H, Zhang D (2013) FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer’s disease via decreasing beta-amyloid production and tau hyperphosphorylation. PLoS One 8(11), e78033. doi: 10.1371/journal.pone.0078033 PubMedCentralPubMedGoogle Scholar
  5. Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HF, Goggins WB, Zee BC, Cheng KF, Fong CY, Wong A, Mok H, Chow MS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CY, Chan MH, Szeto S, Chan IH, Mok V (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28(1):110–113. doi: 10.1097/jcp.0b013e318160862c PubMedGoogle Scholar
  6. Chakravarthi KK, Avadhani R (2013) Beneficial effect of aqueous root extract of Glycyrrhiza glabra on learning and memory using different behavioral models: an experimental study. J Nat Sci Biol Med 4(2):420–425. doi: 10.4103/0976-9668.117025 PubMedCentralPubMedGoogle Scholar
  7. Chen F, Eckman EA, Eckman CB (2006) Reductions in levels of the Alzheimer’s amyloid beta peptide after oral administration of ginsenosides. FASEB J 20(8):1269–1271. doi: 10.1096/fj.05-5530fje PubMedGoogle Scholar
  8. Chen LM, Lin ZY, Zhu YG, Lin N, Zhang J, Pan XD, Chen XC (2012) Ginsenoside Rg1 attenuates beta-amyloid generation via suppressing PPARgamma-regulated BACE1 activity in N2a-APP695 cells. Eur J Pharmacol 675(1–3):15–21. doi: 10.1016/j.ejphar.2011.11.039 PubMedGoogle Scholar
  9. Chen X, Yang Y, Zhang Y (2013) Isobavachalcone and bavachinin from Psoraleae Fructus modulate Abeta42 aggregation process through different mechanisms in vitro. FEBS Lett 587(18):2930–2935. doi: 10.1016/j.febslet.2013.07.037 PubMedGoogle Scholar
  10. Cheng F, Wang X, Lu Y, Zhong X, Zhao Y, Wang Q (2012) Chinese medicine injection qingkailing for treatment of acute ischemia stroke: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med 2012:213172. doi: 10.1155/2012/213172 PubMedCentralPubMedGoogle Scholar
  11. Cheng B, Gong H, Li X, Sun Y, Chen H, Zhang X, Wu Q, Zheng L, Huang K (2013a) Salvianolic acid B inhibits the amyloid formation of human islet amyloid polypeptide and protects pancreatic beta-cells against cytotoxicity. Proteins 81(4):613–621. doi: 10.1002/prot.24216 PubMedGoogle Scholar
  12. Cheng S, Eliaz I, Lin J, Thyagarajan-Sahu A, Sliva D (2013b) Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7. Int J Oncol 42(6):1869–1874. doi: 10.3892/ijo.2013.1902 PubMedCentralPubMedGoogle Scholar
  13. Choi YH, Yon GH, Hong KS, Yoo DS, Choi CW, Park WK, Kong JY, Kim YS, Ryu SY (2008) In vitro BACE-1 inhibitory phenolic components from the seeds of Psoralea corylifolia. Planta Med 74(11):1405–1408. doi: 10.1055/s-2008-1081301 PubMedGoogle Scholar
  14. Chu S, Gu J, Feng L, Liu J, Zhang M, Jia X, Liu M, Yao D (2014) Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses. Int Immunopharmacol 19(2):317–326. doi: 10.1016/j.intimp.2014.01.018 PubMedGoogle Scholar
  15. Esatbeyoglu T, Huebbe P, Ernst IM, Chin D, Wagner AE, Rimbach G (2012) Curcumin–from molecule to biological function. Angew Chem 51(22):5308–5332. doi: 10.1002/anie.201107724 Google Scholar
  16. Fang F, Liu GT (2008) Novel squamosamide derivative (compound FLZ) attenuates Abeta25-35-induced toxicity in SH-SY5Y cells. Acta Pharmacol Sin 29(2):152–160. doi: 10.1111/j.1745-7254.2008.00714.x PubMedGoogle Scholar
  17. Fang F, Wang QL, Liu GT (2012) FLZ, synthetic squamosamide cyclic derivative, attenuates memory deficit and pathological changes in mice with experimentally induced aging. Naunyn Schmiedebergs Arch Pharmacol 385(6):579–585. doi: 10.1007/s00210-012-0745-z PubMedGoogle Scholar
  18. Feng Z, Lu Y, Wu X, Zhao P, Li J, Peng B, Qian Z, Zhu L (2012) Ligustilide alleviates brain damage and improves cognitive function in rats of chronic cerebral hypoperfusion. J Ethnopharmacol 144(2):313–321. doi: 10.1016/j.jep.2012.09.014 PubMedGoogle Scholar
  19. Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, Vassar R, Segal D, Gazit E, Frenkel D, Ovadia M (2011) Orally administrated cinnamon extract reduces beta-amyloid oligomerization and corrects cognitive impairment in Alzheimer’s disease animal models. PLoS One 6(1), e16564. doi: 10.1371/journal.pone.0016564 PubMedCentralPubMedGoogle Scholar
  20. Fujiwara H, Iwasaki K, Furukawa K, Seki T, He M, Maruyama M, Tomita N, Kudo Y, Higuchi M, Saido TC, Maeda S, Takashima A, Hara M, Ohizumi Y, Arai H (2006) Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer’s beta-amyloid proteins. J Neurosci Res 84(2):427–433. doi: 10.1002/jnr.20891 PubMedGoogle Scholar
  21. Giunta B, Hou H, Zhu Y, Salemi J, Ruscin A, Shytle RD, Tan J (2010) Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice. Neurosci Lett 471(3):134–138. doi: 10.1016/j.neulet.2010.01.026 PubMedGoogle Scholar
  22. Gomez-Pinilla F, Tyagi E (2013) Diet and cognition: interplay between cell metabolism and neuronal plasticity. Curr Opin Clin Nutr Metab Care 16(6):726–733. doi: 10.1097/MCO.0b013e328365aae3 PubMedCentralPubMedGoogle Scholar
  23. Green RJ, Murphy AS, Schulz B, Watkins BA, Ferruzzi MG (2007) Common tea formulations modulate in vitro digestive recovery of green tea catechins. Mol Nutr Food Res 51(9):1152–1162. doi: 10.1002/mnfr.200700086 PubMedGoogle Scholar
  24. Gupta SC, Patchva S, Aggarwal BB (2013) Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15(1):195–218. doi: 10.1208/s12248-012-9432-8 PubMedCentralPubMedGoogle Scholar
  25. Ha GT, Wong RK, Zhang Y (2011) Huperzine a as potential treatment of Alzheimer’s disease: an assessment on chemistry, pharmacology, and clinical studies. Chem Biodivers 8(7):1189–1204. doi: 10.1002/cbdv.201000269 PubMedGoogle Scholar
  26. Hamaguchi T, Ono K, Yamada M (2010) REVIEW: curcumin and Alzheimer’s disease. CNS Neurosci Ther 16(5):285–297. doi: 10.1111/j.1755-5949.2010.00147.x PubMedGoogle Scholar
  27. Haniadka R, Saldanha E, Sunita V, Palatty PL, Fayad R, Baliga MS (2013) A review of the gastroprotective effects of ginger (Zingiber officinale Roscoe). Food Function 4(6):845–855. doi: 10.1039/c3fo30337c PubMedGoogle Scholar
  28. Hatip-Al-Khatib I, Egashira N, Mishima K, Iwasaki K, Iwasaki K, Kurauchi K, Inui K, Ikeda T, Fujiwara M (2004) Determination of the effectiveness of components of the herbal medicine Toki-Shakuyaku-San and fractions of Angelica acutiloba in improving the scopolamine-induced impairment of rat’s spatial cognition in eight-armed radial maze test. J Pharmacol Sci 96(1):33–41PubMedGoogle Scholar
  29. Heo JH, Lee ST, Chu K, Oh MJ, Park HJ, Shim JY, Kim M (2008) An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer’s disease. Eur J Neurol 15(8):865–868. doi: 10.1111/j.1468-1331.2008.02157.x PubMedGoogle Scholar
  30. Ho YS, So KF, Chang RC (2011) Drug discovery from Chinese medicine against neurodegeneration in Alzheimer’s and vascular dementia. Chin Med 6:15. doi: 10.1186/1749-8546-6-15 PubMedCentralPubMedGoogle Scholar
  31. Hu Y, Liao HB, Liu P, Guo DH, Rahman K (2009) A bioactive compound from Polygala tenuifolia regulates efficiency of chronic stress on hypothalamic-pituitary-adrenal axis. Pharmazie 64(9):605–608PubMedGoogle Scholar
  32. Hu Y, Li J, Liu P, Chen X, Guo DH, Li QS, Rahman K (2012a) Protection of SH-SY5Y neuronal cells from glutamate-induced apoptosis by 3,6′-disinapoyl sucrose, a bioactive compound isolated from Radix Polygala. J Biomed Biotechnol 2012:1–5. doi: 10.1155/2012/728342 PubMedGoogle Scholar
  33. Hu ZY, Liu G, Cheng XR, Huang Y, Yang S, Qiao SY, Sun L, Zhou WX, Zhang YX (2012b) JD-30, an active fraction extracted from Danggui-Shaoyao-San, decreases beta-amyloid content and deposition, improves LTP reduction and prevents spatial cognition impairment in SAMP8 mice. Exp Gerontol 47(1):14–22. doi: 10.1016/j.exger.2011.09.009 PubMedGoogle Scholar
  34. Hu B, Ting Y, Zeng X, Huang Q (2013) Bioactive peptides/chitosan nanoparticles enhance cellular antioxidant activity of (−)-epigallocatechin-3-gallate. J Agric Food Chem 61(4):875–881. doi: 10.1021/jf304821k PubMedGoogle Scholar
  35. Huai Y, Dong Y, Xu J, Meng N, Song C, Li W, Lv P (2013) L-3-n-butylphthalide protects against vascular dementia via activation of the Akt kinase pathway. Neural Regen Res 8(19):1733–1742. doi: 10.3969/j.issn.1673-5374.2013.19.001 PubMedCentralPubMedGoogle Scholar
  36. Huang SH, Lin CM, Chiang BH (2008) Protective effects of Angelica sinensis extract on amyloid beta-peptide-induced neurotoxicity. Phytomedicine 15(9):710–721. doi: 10.1016/j.phymed.2008.02.022 PubMedGoogle Scholar
  37. Huang T, Fang F, Chen L, Zhu Y, Zhang J, Chen X, Yan SS (2012) Ginsenoside Rg1 attenuates oligomeric Abeta(1–42)-induced mitochondrial dysfunction. Curr Alzheimer Res 9(3):388–395PubMedCentralPubMedGoogle Scholar
  38. Huang HC, Tang D, Xu K, Jiang ZF (2014a) Curcumin attenuates amyloid-beta-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3beta signaling pathway. J Recept Signal Transduct Res 34(1):26–37. doi: 10.3109/10799893.2013.848891 PubMedGoogle Scholar
  39. Huang J, Wu D, Wang J, Li F, Lu L, Gao Y, Zhong Z (2014b) Effects of Panax notoginseng saponin on alpha, beta, and gamma secretase involved in Abeta deposition in SAMP8 mice. Neuroreport 25(2):89–93. doi: 10.1097/WNR.0000000000000048 PubMedGoogle Scholar
  40. Hugel HM, Jackson N (2012) Redox chemistry of green tea polyphenols: therapeutic benefits in neurodegenerative diseases. Mini Rev Med Chem 12(5):380–387PubMedGoogle Scholar
  41. Hugel HM, Jackson N (2014) Danshen diversity defeating dementia. Bioorg Med Chem Lett 24(3):708–716. doi: 10.1016/j.bmcl.2013.12.042 PubMedGoogle Scholar
  42. Hugel HM, Jackson N, May BH, Xue CC (2012) Chinese herbs for dementia diseases. Mini Rev Med Chem 12(5):371–379PubMedGoogle Scholar
  43. Hyung SJ, DeToma AS, Brender JR, Lee S, Vivekanandan S, Kochi A, Choi JS, Ramamoorthy A, Ruotolo BT, Lim MH (2013) Insights into antiamyloidogenic properties of the green tea extract (−)-epigallocatechin-3-gallate toward metal-associated amyloid-beta species. Proc Natl Acad Sci U S A 110(10):3743–3748. doi: 10.1073/pnas.1220326110 PubMedCentralPubMedGoogle Scholar
  44. International WHOaAsD (2012) Dementia: a public health priority. WHO Regional Office for Europe, CopenhagenGoogle Scholar
  45. Iwasaki K, Maruyama M, Tomita N, Furukawa K, Nemoto M, Fujiwara H, Seki T, Fujii M, Kodama M, Arai H (2005a) Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. J Clin Psychiatry 66(12):1612–1613PubMedGoogle Scholar
  46. Iwasaki K, Satoh-Nakagawa T, Maruyama M, Monma Y, Nemoto M, Tomita N, Tanji H, Fujiwara H, Seki T, Fujii M, Arai H, Sasaki H (2005b) A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 66(2):248–252PubMedGoogle Scholar
  47. Jayasena T, Poljak A, Smythe G, Braidy N, Munch G, Sachdev P (2013) The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer’s disease. Ageing Res Rev 12(4):867–883. doi: 10.1016/j.arr.2013.06.003 PubMedGoogle Scholar
  48. Kakkar V, Mishra AK, Chuttani K, Kaur IP (2013) Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain. Int J Pharm 448(2):354–359. doi: 10.1016/j.ijpharm.2013.03.046 PubMedGoogle Scholar
  49. Kang RX, Zhang JJ (2012) A natural squamosamide derivative FLZ inhibits homocysteine-induced rat brain microvascular endothelial cells dysfunction. Biochem Biophys Res Commun 417(4):1176–1181. doi: 10.1016/j.bbrc.2011.12.094 PubMedGoogle Scholar
  50. Kang MS, Baek SH, Chun YS, Moore AZ, Landman N, Berman D, Yang HO, Morishima-Kawashima M, Osawa S, Funamoto S, Ihara Y, Di Paolo G, Park JH, Chung S, Kim TW (2013) Modulation of lipid kinase PI4KIIalpha activity and lipid raft association of presenilin 1 underlies gamma-secretase inhibition by ginsenoside (20S)-Rg3. J Biol Chem 288(29):20868–20882. doi: 10.1074/jbc.M112.445734 PubMedCentralPubMedGoogle Scholar
  51. Kanno H, Kawakami Z, Iizuka S, Tabuchi M, Mizoguchi K, Ikarashi Y, Kase Y (2013) Glycyrrhiza and Uncaria Hook contribute to protective effect of traditional Japanese medicine yokukansan against amyloid beta oligomer-induced neuronal death. J Ethnopharmacol 149(1):360–370. doi: 10.1016/j.jep.2013.06.052 PubMedGoogle Scholar
  52. Karpagam V, Sathishkumar N, Sathiyamoorthy S, Rasappan P, Shila S, Kim YJ, Yang DC (2013) Identification of BACE1 inhibitors from Panax ginseng saponins-An Insilco approach. Comput Biol Med 43(8):1037–1044. doi: 10.1016/j.compbiomed.2013.05.009 PubMedGoogle Scholar
  53. Kim DS, Kim JY, Han YS (2007) Alzheimer’s disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1–42) insult. J Altern Complement Med 13(3):333–340. doi: 10.1089/acm.2006.6107 PubMedGoogle Scholar
  54. Kim HJ, Kim P, Shin CY (2013a) A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. J Ginseng Res 37(1):8–29. doi: 10.5142/jgr.2013.37.8 PubMedCentralPubMedGoogle Scholar
  55. Kim J, Kim SH, Lee DS, Lee DJ, Kim SH, Chung S, Yang HO (2013b) Effects of fermented ginseng on memory impairment and beta-amyloid reduction in Alzheimer’s disease experimental models. J Ginseng Res 37(1):100–107. doi: 10.5142/jgr.2013.37.100 PubMedCentralPubMedGoogle Scholar
  56. Kong DX, Li XJ, Zhang HY (2009) Where is the hope for drug discovery? Let history tell the future. Drug Discov Today 14(3–4):115–119. doi: 10.1016/j.drudis.2008.07.002 PubMedGoogle Scholar
  57. Kong XC, Zhang D, Qian C, Liu GT, Bao XQ (2011) FLZ, a novel HSP27 and HSP70 inducer, protects SH-SY5Y cells from apoptosis caused by MPP(+). Brain Res 1383:99–107. doi: 10.1016/j.brainres.2011.01.093 PubMedGoogle Scholar
  58. Kuang X, Yao Y, Du JR, Liu YX, Wang CY, Qian ZM (2006) Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice. Brain Res 1102(1):145–153. doi: 10.1016/j.brainres.2006.04.110 PubMedGoogle Scholar
  59. Kumaraswamy P, Sethuraman S, Krishnan UM (2013) Mechanistic insights of curcumin interactions with the core-recognition motif of beta-amyloid peptide. J Agric Food Chem 61(13):3278–3285. doi: 10.1021/jf4000709 PubMedGoogle Scholar
  60. Lambert JD, Sang S, Hong J, Kwon SJ, Lee MJ, Ho CT, Yang CS (2006) Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab Dispos 34(12):2111–2116. doi: 10.1124/dmd.106.011460 PubMedGoogle Scholar
  61. Lee SH, Jung BH, Choi SY, Kim SY, Lee EH, Chung BC (2006a) Influence of ginsenoside Rb1 on brain neurosteroid during acute immobilization stress. Arch Pharm Res 29(7):566–569PubMedGoogle Scholar
  62. Lee SH, Jung BH, Kim SY, Lee EH, Chung BC (2006b) The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. Pharmacol Res 54(1):46–49. doi: 10.1016/j.phrs.2006.02.001 PubMedGoogle Scholar
  63. Lee YK, Yuk DY, Lee JW, Lee SY, Ha TY, Oh KW, Yun YP, Hong JT (2009) (−)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency. Brain Res 1250:164–174. doi: 10.1016/j.brainres.2008.10.012 PubMedGoogle Scholar
  64. Lee YJ, Choi IS, Park MH, Lee YM, Song JK, Kim YH, Kim KH, Hwang DY, Jeong JH, Yun YP, Oh KW, Jung JK, Han SB, Hong JT (2011a) 4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. Free Radic Biol Med 50(1):66–77. doi: 10.1016/j.freeradbiomed.2010.10.698 PubMedGoogle Scholar
  65. Lee YJ, Lee YM, Lee CK, Jung JK, Han SB, Hong JT (2011b) Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther 130(2):157–176. doi: 10.1016/j.pharmthera.2011.01.010 PubMedGoogle Scholar
  66. Lee YJ, Choi DY, Han SB, Kim YH, Kim KH, Hwang BY, Kang JK, Lee BJ, Oh KW, Hong JT (2012) Inhibitory effect of ethanol extract of Magnolia officinalis on memory impairment and amyloidogenesis in a transgenic mouse model of Alzheimer’s disease via regulating beta-secretase activity. Phytother Res 26(12):1884–1892. doi: 10.1002/ptr.4643 PubMedGoogle Scholar
  67. Lee E, Eom JE, Kim HL, Baek KH, Jun KY, Kim HJ, Lee M, Mook-Jung I, Kwon Y (2013) Effect of conjugated linoleic acid, mu-calpain inhibitor, on pathogenesis of Alzheimer’s disease. Biochim Biophys Acta 1831(4):709–718. doi: 10.1016/j.bbalip.2012.12.003 PubMedGoogle Scholar
  68. Lewandowska U, Szewczyk K, Hrabec E, Janecka A, Gorlach S (2013) Overview of metabolism and bioavailability enhancement of polyphenols. J Agric Food Chem 61(50):12183–12199. doi: 10.1021/jf404439b PubMedGoogle Scholar
  69. Li N, Liu GT (2010) The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice. Acta Pharmacol Sin 31(3):265–272. doi: 10.1038/aps.2010.3 PubMedCentralPubMedGoogle Scholar
  70. Li B, Du W, Jin J, Du Q (2012) Preservation of (−)-epigallocatechin-3-gallate antioxidant properties loaded in heat treated beta-lactoglobulin nanoparticles. J Agric Food Chem 60(13):3477–3484. doi: 10.1021/jf300307t PubMedGoogle Scholar
  71. Li L, Liu Z, Liu J, Tai X, Hu X, Liu X, Wu Z, Zhang G, Shi M, Zhao G (2013a) Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Neurobiol Dis 54:320–328. doi: 10.1016/j.nbd.2013.01.002 PubMedGoogle Scholar
  72. Li X, Chen W, Chen D (2013b) Protective effect against hydroxyl-induced DNA damage and antioxidant activity of radix glycyrrhizae (liquorice root). Adva Pharm Bull 3(1):167–173. doi: 10.5681/apb.2013.028 Google Scholar
  73. Liang JH, Du J, Xu LD, Jiang T, Hao S, Bi J, Jiang B (2009) Catalpol protects primary cultured cortical neurons induced by Abeta(1–42) through a mitochondrial-dependent caspase pathway. Neurochem Int 55(8):741–746. doi: 10.1016/j.neuint.2009.07.004 PubMedGoogle Scholar
  74. Liao WP, Chen L, Yi YH, Sun WW, Gao MM, Su T, Yang SQ (2005) Study of antiepileptic effect of extracts from Acorus tatarinowii Schott. Epilepsia 46(Suppl 1):21–24. doi: 10.1111/j.0013-9580.2005.461007.x PubMedGoogle Scholar
  75. Lin Z, Gu J, Xiu J, Mi T, Dong J, Tiwari JK (2012) Traditional Chinese medicine for senile dementia. Evid Based Complement Alternat Med 2012:692621. doi: 10.1155/2012/692621 PubMedCentralPubMedGoogle Scholar
  76. Ling Y, Li Z, Chen M, Sun Z, Fan M, Huang C (2013) Analysis and detection of the chemical constituents of Radix Polygalae and their metabolites in rats after oral administration by ultra high-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. J Pharm Biomed Anal 85:1–13. doi: 10.1016/j.jpba.2013.06.011 PubMedGoogle Scholar
  77. Liu P, Zhao L, Zhang SL, Xiang JZ (2009) Modified Wendan decoction can attenuate neurotoxic action associated with Alzheimer’s disease. Evid Based Complement Alternat Med 6(3):325–330. doi: 10.1093/ecam/nem103 PubMedCentralPubMedGoogle Scholar
  78. Liu LF, Durairajan SS, Lu JH, Koo I, Li M (2012) In vitro screening on amyloid precursor protein modulation of plants used in Ayurvedic and traditional Chinese medicine for memory improvement. J Ethnopharmacol 141(2):754–760. doi: 10.1016/j.jep.2011.08.065 PubMedGoogle Scholar
  79. Liu Z, Zhao X, Liu B, Liu AJ, Li H, Mao X, Wu B, Bi KS, Jia Y (2014) Jujuboside A, a neuroprotective agent from semen Ziziphi Spinosae ameliorates behavioral disorders of the dementia mouse model induced by Abeta 1–42. Eur J Pharmacol 738:206–213. doi: 10.1016/j.ejphar.2014.05.041 PubMedGoogle Scholar
  80. Lotito SB, Frei B (2006) Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 41(12):1727–1746. doi: 10.1016/j.freeradbiomed.2006.04.033 PubMedGoogle Scholar
  81. Lv J, Jia H, Jiang Y, Ruan Y, Liu Z, Yue W, Beyreuther K, Tu P, Zhang D (2009) Tenuifolin, an extract derived from tenuigenin, inhibits amyloid-beta secretion in vitro. Acta Physiol 196(4):419–425. doi: 10.1111/j.1748-1716.2009.01961.x Google Scholar
  82. Man SC, Chan KW, Lu JH, Durairajan SS, Liu LF, Li M (2012) Systematic review on the efficacy and safety of herbal medicines for vascular dementia. Evid Based Complement Alternat Med 2012:426215. doi: 10.1155/2012/426215 PubMedCentralPubMedGoogle Scholar
  83. Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20(4):415–418. doi: 10.1038/nm.3466 PubMedGoogle Scholar
  84. May BH, Yang AW, Zhang AL, Owens MD, Bennett L, Head R, Cobiac L, Li CG, Hugel H, Story DF, Xue CC (2009) Chinese herbal medicine for mild cognitive impairment and age associated memory impairment: a review of randomised controlled trials. Biogerontology 10(2):109–123. doi: 10.1007/s10522-008-9163-5 PubMedGoogle Scholar
  85. May BH, Lu C, Bennett L, Hugel HM, Xue CC (2012) Evaluating the traditional Chinese literature for herbal formulae and individual herbs used for age-related dementia and memory impairment. Biogerontology 13(3):299–312. doi: 10.1007/s10522-012-9375-6 PubMedGoogle Scholar
  86. Mei Z, Zhang F, Tao L, Zheng W, Cao Y, Wang Z, Tang S, Le K, Chen S, Pi R, Liu P (2009) Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro. Neurosci Lett 452(2):90–95. doi: 10.1016/j.neulet.2009.01.013 PubMedGoogle Scholar
  87. Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I (2014) Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. Br J Nutr 111(7):1263–1271. doi: 10.1017/S0007114513003784 PubMedGoogle Scholar
  88. Mourtas S, Lazar AN, Markoutsa E, Duyckaerts C, Antimisiaris SG (2014) Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur J Med Chem 80:175–183. doi: 10.1016/j.ejmech.2014.04.050 PubMedGoogle Scholar
  89. Nastase AF, Boyd DB (2012) Simple structure-based approach for predicting the activity of inhibitors of beta-secretase (BACE1) associated with Alzheimer’s disease. J Chem Inf Model 52(12):3302–3307. doi: 10.1021/ci300331d PubMedGoogle Scholar
  90. Palhano FL, Lee J, Grimster NP, Kelly JW (2013) Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. J Am Chem Soc 135(20):7503–7510. doi: 10.1021/ja3115696 PubMedCentralPubMedGoogle Scholar
  91. Pang HY, Liu G, Liu GT (2009) Compound FLZ inhibits lipopolysaccharide-induced inflammatory effects via down-regulation of the TAK-IKK and TAK-JNK/p38MAPK pathways in RAW264.7 macrophages. Acta Pharmacol Sin 30(2):209–218. doi: 10.1038/aps.2008.29 PubMedCentralPubMedGoogle Scholar
  92. Peng Y, Xing C, Lemere CA, Chen G, Wang L, Feng Y, Wang X (2008) l-3-n-Butylphthalide ameliorates beta-amyloid-induced neuronal toxicity in cultured neuronal cells. Neurosci Lett 434(2):224–229. doi: 10.1016/j.neulet.2008.01.080 PubMedGoogle Scholar
  93. Peng Y, Hu Y, Xu S, Li P, Li J, Lu L, Yang H, Feng N, Wang L, Wang X (2012) L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AbetaPP/PS1-Alzheimer’s transgenic mice. J Alzheimers Dis 29(2):379–391. doi: 10.3233/JAD-2011-111577 PubMedGoogle Scholar
  94. Peng Y, Hu Y, Xu S, Rong X, Li J, Li P, Wang L, Yang J, Wang X (2014) Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and tau pathologies in a mouse model of Alzheimer’s disease. J Pharmacol Exp Ther 350(2):361–374. doi: 10.1124/jpet.114.213140 PubMedGoogle Scholar
  95. Pengelly A, Snow J, Mills SY, Scholey A, Wesnes K, Butler LR (2012) Short-term study on the effects of rosemary on cognitive function in an elderly population. J Med Food 15(1):10–17. doi: 10.1089/jmf.2011.0005 PubMedGoogle Scholar
  96. Qin Y, Pan X, Tang TT, Zhou L, Gong XG (2011) Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels. Chem Biol Interact 193(3):246–253. doi: 10.1016/j.cbi.2011.07.004 PubMedGoogle Scholar
  97. Quan Q, Wang J, Li X, Wang Y (2013) Ginsenoside Rg1 decreases Abeta(1–42) level by upregulating PPARgamma and IDE expression in the hippocampus of a rat model of Alzheimer’s disease. PLoS One 8(3), e59155. doi: 10.1371/journal.pone.0059155 PubMedCentralPubMedGoogle Scholar
  98. Schaffer S, Halliwell B (2012) Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes Nutr 7(2):99–109. doi: 10.1007/s12263-011-0255-5 PubMedCentralPubMedGoogle Scholar
  99. Shen J, Chen X (2013) Drug discovery from traditional Chinese medicine for neurogenesis: implications for stroke and neurodegenerative diseases. In: Adams JD, Lien EJ (eds) Traditional Chinese medicine: scientific basis for its use. Royal Society of Chemistry Publishing, Cambridge, pp 204–237Google Scholar
  100. Shi J, Wang Y, Luo G (2012) Ligustrazine phosphate ethosomes for treatment of Alzheimer’s disease, in vitro and in animal model studies. AAPS Pharm Sci Tech 13(2):485–492. doi: 10.1208/s12249-012-9767-6 Google Scholar
  101. Shi C, Na N, Zhu X, Xu J (2013) Estrogenic effect of ginsenoside Rg1 on APP processing in post-menopausal platelets. Platelets 24(1):51–62. doi: 10.3109/09537104.2012.654839 PubMedGoogle Scholar
  102. Shinno H, Inami Y, Inagaki T, Nakamura Y, Horiguchi J (2008) Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia. Prog Neuropsychopharmacol Biol Psychiatry 32(3):881–885. doi: 10.1016/j.pnpbp.2007.12.027 PubMedGoogle Scholar
  103. Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C (2008) Challenges for research on polyphenols from foods in Alzheimer’s disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem 56(13):4855–4873. doi: 10.1021/jf0735073 PubMedGoogle Scholar
  104. Smith A, Giunta B, Bickford PC, Fountain M, Tan J, Shytle RD (2010) Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer’s disease. Int J Pharm 389(1–2):207–212. doi: 10.1016/j.ijpharm.2010.01.012 PubMedGoogle Scholar
  105. Smriga M, Saito H, Nishiyama N (1995) Hoelen (Poria Cocos Wolf) and ginseng (Panax Ginseng C. A. Meyer), the ingredients of a Chinese prescription DX-9386, individually promote hippocampal long-term potentiation in vivo. Biol Pharm Bull 18(4):518–522PubMedGoogle Scholar
  106. Tai W, Ye X, Bao X, Zhao B, Wang X, Zhang D (2013) Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson’s disease models. Neuropharmacology 75:201–212. doi: 10.1016/j.neuropharm.2013.07.020 PubMedGoogle Scholar
  107. Tiwari SK, Agarwal S, Seth B, Yadav A, Nair S, Bhatnagar P, Karmakar M, Kumari M, Chauhan LK, Patel DK, Srivastava V, Singh D, Gupta SK, Tripathi A, Chaturvedi RK, Gupta KC (2014) Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer’s disease model via canonical Wnt/beta-catenin pathway. ACS Nano 8(1):76–103. doi: 10.1021/nn405077y PubMedGoogle Scholar
  108. Ulijaszek SJ, Mann N, Elton S (2012) Evolving human nutrition: implications for public health, vol 64. Cambridge studies in biological and evolutionary anthropology. Cambridge University Press, Cambridge. doi:
  109. van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJ, Gross G, Roger LC, Possemiers S, Smilde AK, Dore J, Westerhuis JA, Van de Wiele T (2011) Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci U S A 108(Suppl 1):4531–4538. doi: 10.1073/pnas.1000098107 PubMedCentralPubMedGoogle Scholar
  110. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Despres S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477(7362):90–94. doi: 10.1038/nature10357 PubMedCentralPubMedGoogle Scholar
  111. Wang SH, Liu FF, Dong XY, Sun Y (2010) Thermodynamic analysis of the molecular interactions between amyloid beta-peptide 42 and (−)-epigallocatechin-3-gallate. J Phys Chem B 114(35):11576–11583. doi: 10.1021/jp1001435 PubMedGoogle Scholar
  112. Wang Y, Tang XC, Zhang HY (2012) Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice. J Neurosci Res 90(2):508–517. doi: 10.1002/jnr.22775 PubMedGoogle Scholar
  113. Wang Q, Yu X, Patal K, Hu R, Chuang S, Zhang G, Zheng J (2013) Tanshinones inhibit amyloid aggregation by amyloid-beta peptide, disaggregate amyloid fibrils, and protect cultured cells. ACS Chem Neurosci 4(6):1004–1015. doi: 10.1021/cn400051e PubMedCentralPubMedGoogle Scholar
  114. Wang P, Su C, Li R, Wang H, Ren Y, Sun H, Yang J, Sun J, Shi J, Tian J, Jiang S (2014) Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice. J Neurosci Res 92(2):218–231. doi: 10.1002/jnr.23322 PubMedGoogle Scholar
  115. Wimo A, Jonsson L, Bond J, Prince M, Winblad B, Alzheimer Disease I (2013) The worldwide economic impact of dementia 2010. Alzheimers Dement 9(1):1–11. doi: 10.1016/j.jalz.2012.11.006, e13PubMedGoogle Scholar
  116. Witte AV, Fobker M, Gellner R, Knecht S, Floel A (2009) Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci U S A 106(4):1255–1260. doi: 10.1073/pnas.0808587106 PubMedCentralPubMedGoogle Scholar
  117. Wu AG, Wong VK, Xu SW, Chan WK, Ng CI, Liu L, Law BY (2013a) Onjisaponin B derived from Radix Polygalae enhances autophagy and accelerates the degradation of mutant alpha-synuclein and huntingtin in PC-12 cells. Int J Mol Sci 14(11):22618–22641. doi: 10.3390/ijms141122618 PubMedCentralPubMedGoogle Scholar
  118. Wu S, Sun K, Wang X, Wang D, Wan X, Zhang J (2013b) Protonation of epigallocatechin-3-gallate (EGCG) results in massive aggregation and reduced oral bioavailability of EGCG-dispersed selenium nanoparticles. J Agric Food Chem 61(30):7268–7275. doi: 10.1021/jf4000083 PubMedGoogle Scholar
  119. Xian YF, Lin ZX, Mao QQ, Hu Z, Zhao M, Che CT, Ip SP (2012) Bioassay-guided isolation of neuroprotective compounds from Uncaria rhynchophylla against beta-amyloid-induced neurotoxicity. Evid Based Complement Alternat Med 2012:802625. doi: 10.1155/2012/802625 PubMedCentralPubMedGoogle Scholar
  120. Xiao J, Chen X, Zhang L, Talbot SG, Li GC, Xu M (2008) Investigation of the mechanism of enhanced effect of EGCG on huperzine A’s inhibition of acetylcholinesterase activity in rats by a multispectroscopic method. J Agric Food Chem 56(3):910–915. doi: 10.1021/jf073036k PubMedGoogle Scholar
  121. Xin J, Zhang J, Yang Y, Deng M, Xie X (2013) Radix Angelica Sinensis that contains the component Z-ligustilide promotes adult neurogenesis to mediate recovery from cognitive impairment. Curr Neurovasc Res 10(4):304–315PubMedGoogle Scholar
  122. Yang L, Hao J, Zhang J, Xia W, Dong X, Hu X, Kong F, Cui X (2009) Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin. J Pharm Pharmacol 61(3):375–380. doi: 10.1211/jpp/61.03.0013 PubMedGoogle Scholar
  123. Yang G, Wang Y, Tian J, Liu JP (2013) Huperzine A for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trials. PLoS One 8(9), e74916. doi: 10.1371/journal.pone.0074916 PubMedCentralPubMedGoogle Scholar
  124. Ye X, Tai W, Bao X, Chen X, Zhang D (2014) FLZ inhibited gamma-secretase selectively and decreased Abeta mitochondrial production in APP-SH-SY5Y cells. Naunyn Schmiedebergs Arch Pharmacol 387(1):75–85. doi: 10.1007/s00210-013-0918-4 PubMedGoogle Scholar
  125. Yoshida H, Meng P, Matsumiya T, Tanji K, Hayakari R, Xing F, Wang L, Tsuruga K, Tanaka H, Mimura J, Kosaka K, Itoh K, Takahashi I, Imaizumi T (2014) Carnosic acid suppresses the production of amyloid-beta 1–42 and 1–43 by inducing an alpha-secretase TACE/ADAM17 in U373MG human astrocytoma cells. Neurosci Res 79:83–93. doi: 10.1016/j.neures.2013.11.004 PubMedGoogle Scholar
  126. Yue J, Dong BR, Lin X, Yang M, Wu HM, Wu T (2012) Huperzine A for mild cognitive impairment. Cochrane Database Syst Rev (12), CD008827. doi: 10.1002/14651858.CD008827.pub2 Google Scholar
  127. Zeng GF, Zhang ZY, Lu L, Xiao DQ, Zong SH, He JM (2013) Protective effects of ginger root extract on Alzheimer disease-induced behavioral dysfunction in rats. Rejuvenation Res 16(2):124–133. doi: 10.1089/rej.2012.1389 PubMedGoogle Scholar
  128. Zhang YJ, Wu L, Zhang QL, Li J, Yin FX, Yuan Y (2011) Pharmacokinetics of phenolic compounds of Danshen extract in rat blood and brain by microdialysis sampling. J Ethnopharmacol 136(1):129–136. doi: 10.1016/j.jep.2011.04.023 PubMedGoogle Scholar
  129. Zhang J, Li P, Wang Y, Liu J, Zhang Z, Cheng W, Wang Y (2013a) Ameliorative effects of a combination of baicalin, jasminoidin and cholic acid on ibotenic acid-induced dementia model in rats. PLoS One 8(2), e56658. doi: 10.1371/journal.pone.0056658 PubMedCentralPubMedGoogle Scholar
  130. Zhang SQ, Sawmiller D, Li S, Rezai-Zadeh K, Hou H, Zhou S, Shytle D, Giunta B, Fernandez F, Mori T, Tan J (2013b) Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation. PLoS One 8(8), e71913. doi: 10.1371/journal.pone.0071913 PubMedCentralPubMedGoogle Scholar
  131. Zhang X, Tian Y, Li Z, Tian X, Sun H, Liu H, Moore A, Ran C (2013c) Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer’s disease. J Am Chem Soc 135(44):16397–16409. doi: 10.1021/ja405239v PubMedCentralPubMedGoogle Scholar
  132. Zhang Z, Du GJ, Wang CZ, Wen XD, Calway T, Li Z, He TC, Du W, Bissonnette M, Musch MW, Chang EB, Yuan CS (2013d) Compound K, a ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53-p21 interactions. Int J Mol Sci 14(2):2980–2995. doi: 10.3390/ijms14022980 PubMedCentralPubMedGoogle Scholar
  133. Zhang XY, Qiao H, Shi YB (2014) HPLC method with fluorescence deduction for the determination of ligustilide in rat plasma and its pharmacokinetics. Pharm Biol 52:21–30PubMedGoogle Scholar
  134. Zhao L, Wei MJ, He M, Jin WB, Zhai HS, Yao WF (2008) The effects of tetramethylpyrazine on learning and memory abilities of mice with Alzheimer’s disease and its possible mechanism. Chin Pharmacol Bull 24:1088–1092Google Scholar
  135. Zhao W, Xu S, Peng Y, Ji X, Cao D, Li J, Liu B, Shi Q, Wang L, Wang X (2013) Potassium 2-(1-hydroxypentyl)-benzoate improves learning and memory deficits in chronic cerebral hypoperfused rats. Neurosci Lett 541:155–160. doi: 10.1016/j.neulet.2013.01.053 PubMedGoogle Scholar
  136. Zhou Y, Li W, Xu L, Chen L (2011) In Salvia miltiorrhiza, phenolic acids possess protective properties against amyloid beta-induced cytotoxicity, and tanshinones act as acetylcholinesterase inhibitors. Environ Toxicol Pharmacol 31(3):443–452. doi: 10.1016/j.etap.2011.02.006 PubMedGoogle Scholar
  137. Zhou L, Hou Y, Yang Q, Du X, Li M, Yuan M, Zhou Z (2012) Tetrahydroxystilbene glucoside improves the learning and memory of amyloid-beta((1)(−)(4)(2))-injected rats and may be connected to synaptic changes in the hippocampus. Can J Physiol Pharmacol 90(11):1446–1455. doi: 10.1139/y2012-121 PubMedGoogle Scholar
  138. Zhu Z, Li C, Wang X, Yang Z, Chen J, Hu L, Jiang H, Shen X (2010) 2,2′,4′-trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice. J Neurochem 114(2):374–385. doi: 10.1111/j.1471-4159.2010.06751.x PubMedGoogle Scholar
  139. Zhu KY, Xu SL, Choi RC, Yan AL, Dong TT, Tsim KW (2013) Kai-xin-san, a Chinese herbal decoction containing ginseng radix et rhizoma, polygalae radix, acori tatarinowii rhizoma, and poria, stimulates the expression and secretion of neurotrophic factors in cultured astrocytes. Evid Based Complement Alternat Med 2013:731385. doi: 10.1155/2013/731385 PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.School of Applied Sciences & Health Innovations Research InstituteRMIT UniversityMelbourneAustralia

Personalised recommendations